Reata pharmaceuticals (nasdaq:reta) in the past three months, reata pharmaceuticals insiders have not sold or bought any company stock. (nasdaq:reta) is not the least popular stock in this group but hedge fund interest is still below average.
Is reata pharmaceuticals stock a good buy in 2021, according to wall street analysts?
Reata pharmaceuticals stock buy or sell. Quote stock analysis news price vs fair value sustainability trailing returns. Finally, we have a pdufa. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Reata pharmaceuticals has a 1 year low of $76.34 and a 1 year high of $184.00. At reata pharmaceuticals, our mission is to develop innovative therapies that change patients’ lives for the better. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be.
We're not expecting reata pharmaceuticals to pay a dividend over the next 12 months. Notably, that recent sale by colin meyer is the biggest insider sale of reata pharmaceuticals shares that we've seen in the last year. Only 31.70% of the stock of reata pharmaceuticals is held by insiders.
Make sure to utilize our earnings esp filter to uncover the best stocks to buy or sell before they've reported. Reata pharmaceuticals is not the only stock that insiders are buying. So we know that an insider sold shares at around the present.
Over the last 12 months, reata pharmaceuticals's shares have ranged in value from as little as $76.34 up to $186.817. A popular way to gauge a stock's volatility is its beta. Reata pharmaceuticals started at buy with $38 stock price target at stifel nicolaus.
This highflying biotech stock tumbled after shuttering two key studies; 23, 2017 at 8:50 a.m. Reata pharmaceuticals share price volatility.
This price target is based on 3 analysts offering 12 month price targets for reata pharmaceuticals in the last 3 months. When looking into those indicators for reata pharmaceuticals inc. Out of 3 analysts, 3 ( 100% ) are recommending reta as a strong buy, 0 ( 0% ) are recommending reta as a buy, 0 ( 0% ) are recommending reta as a hold, 0 ( 0% ) are.
What is the reata pharmaceuticals inc stock quote today? Yes, reata pharmaceuticals inc is a publicly traded company. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
64.30% of the stock of reata pharmaceuticals is held by institutions. The average price target is $217.25, with a high forecast of $244.00 and a low forecast of $155.00. The reata pharmaceuticals inc stock price is 81.40 usd today.
Or recommendation to buy or sell securities. According to the issued ratings of 3 analysts in the last year, the consensus rating for reata pharmaceuticals stock is buy based on the current 3 buy ratings for reta. Is reata pharmaceuticals inc stock public?
Reata pharma shows rising relative strength; Is it the right time to buy or sell? Shares of reata pharmaceuticals stock opened at $105.41 on thursday.
(reta) reports q3 loss, tops revenue. Reata pharmaceuticals inc is a. The consensus among 3 wall street analysts covering ( nasdaq :
Reta ) stock is to strong buy reta stock.
